Abstract:As is well known that colorectal cancer is the third most common cancer in the world, and radiation treatment plays a vital role in colorectal cancer therapy, but radiation resistance is a significant problem in the treatment of colorectal cancer. As an important member of the non-coding RNA family, long non-coding RNAs (lncRNAs) have been found that it plays a role in the occurrence and progression of colorectal cancer in recent years. However, little is known about the effect of lncRNA on colorectal cancer sensitivity to radiotherapy. We found that lnc-TLCD2-1 was significantly differentially expressed in radiation-tolerant CCL244 cell lines and radiation-sensitive HCT116 cell lines, suggesting that lnc-TLCD2-1 may regulate the radiosensitivity of colorectal cancer, and the relevant underlying mechanism was investigated. Cell clone formation assay, flow cytometry, and cell counting kit 8 (CCK8) were used to detect radiation sensitivity, apoptosis, and proliferation of colorectal cancer cells, respectively; Quantitative real-time PCR and western blot were used to detect the expression of genes; the direct interaction between lnc-TLCD2-1 and hsa-miR-193a-5p was verified by dual luciferase reporter assays; GEPIA, Starbase, TIMER and DAVID were used to complete expression of lnc-TLCD2-1, miR-193a-5p,YY1 and NF-кB-P65 in colorectal cancer, correlation, immune cell infiltration, GO and KEGG enrichment analysis. Clinical prognostic analysis data were obtained from GSE17536 dataset. After radiotherapy for HCT116, the expression of lnc-TLCD2-1 was increased, and the expression of hsa-miR-193a-5p was significantly decreased, while that of CCL244 was the opposite, and the change range of lnc-TLCD2-1 was relatively small. HCT116 with overexpression of lnc-TLCD2-1 after radiation treatment, the number of cell colonies significantly increased, and cell apoptosis decreased compared with the negative control group. The cell colonies and apoptosis of CCL244 with disturbed expression of lnc-TLCD2-1 were opposite to those of HCT116. Lnc-TLCD2-1 can regulate the expression of YY1/NF-кB-P65 by targeting miR-193a-5p. Lnc-TLCD2-1 can promote the proliferation of colorectal cancer. High expression of lnc-TLCD2-1 independently predicted a shorter survival. Lnc-TLCD2-1 is associated with radiation resistance and short survival in colorectal cancer patients. In addition, Lnc-TLCD2-1 can promote the proliferation of colorectal cancer. Our study provides a scientific basis for targeting lnc-TLCD2-1 in colorectal cancer radiation resistance interventions and selection of prognostic biomarker.

The Role of LncRNAs in the Regulation of Radiotherapy Sensitivity in Cervical Cancer

Molecular mechanisms of long noncoding RNAs associated with cervical cancer radiosensitivity

Dysregulation Of Long Non-Coding Rna In Breast Cancer: An Overview Of Mechanism And Clinical Implication

Long Noncoding RNA LINC00958 Regulates Cell Sensitivity to Radiotherapy Through RRM2 by Binding to Microrna‐5095 in Cervical Cancer

Radiotherapy and breast cancer: finally, an lncRNA perspective on radiosensitivity and radioresistance

LncRNA SNHG12 regulates the radiosensitivity of cervical cancer through the miR-148a/CDK1 pathway

Role of Non-coding RNAs on the Radiotherapy Sensitivity and Resistance in Cancer Cells

Review of possible mechanisms of radiotherapy resistance in cervical cancer

Silencing of lncRNA H19 Enhances the Sensitivity to X-rays and Carbon-Ions Through the miR-130a-3p /WNK3 Signal Axis in Non-Small-Cell Lung Cancer Cells

Heavy-Ion Carbon Radiation Regulates Long Non-Coding Rnas In Cervical Cancer Hela Cells

Comprehensive review of LncRNA-mediated therapeutic resistance in non-small cell lung cancer

Non-coding RNAs in radiotherapy resistance: Roles and therapeutic implications in gastrointestinal cancer

Regulation of lnc-TLCD2-1 on Radiation Sensitivity of Colorectal Cancer and Comprehensive Analysis of Its Mechanism

Enhancement of Cisplatin-Induced Cytotoxicity Against Cervical Cancer Spheroid Cells by Targeting Long Non-Coding RNAs.

Translation regulatory long non‐coding RNA 1 negatively regulates cell radiosensitivity via the miR‐22‐3p/SP1 axis in non‐small cell lung cancer

Silencing of the lncRNA H19 enhances sensitivity to X-ray and carbon-ions through the miR-130a-3p /WNK3 signaling axis in NSCLC cells

Identification of Biomarkers for Cervical Cancer Radiotherapy Resistance Based on RNA Sequencing Data

Long Non-Coding RNA ROR Promotes Radioresistance in Hepatocelluar Carcinoma Cells by Acting As a Cerna for Microrna-145 to Regulate RAD18 Expression

The Emerging Role and Promise of Long Noncoding RNAs in Lung Cancer Treatment

Role of Long Non-Coding RNAs in the Chemoresistance of Gastric Cancer: A Systematic Review

LINC01094 Triggers Radio-Resistance in Clear Cell Renal Cell Carcinoma Via Mir-577/Chek2/foxm1 Axis